PubMed ID: 15364717 Author(s): Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, Damico CM, Patel S. Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor …
Janice Lokken
Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
PubMed ID: 15364716 Author(s): Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, Patel S. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. …
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model.
PubMed ID: 12003610 Author(s): Grostern RJ, Bryar PJ, Zimbric ML, Darjatmoko SR, Lissauer BJ, Lindstrom MJ, Lokken JM, Strugnell SA, Albert DM. Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch …
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.
PubMed ID: 12545685 Author(s): Dawson DG, Gleiser J, Zimbric ML, Darjatmoko SR, Frisbie JC, Lokken JM, Lindstrom MJ, Audo I, Strugnell SA, Albert DM. Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag …
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
PubMed ID: 9856795 Author(s): Syed NA, Windle JJ, Darjatmoko SR, Lokken JM, Steeves RA, Chappell R, Wallow IH, Koop BA, Mangold G, Howes KA, Albert DM. Transgenic mice with pigmented intraocular tumors: tissue of origin …